Home - Products - Others - Other Targets - [D-Ala2,Met5]- β-Casomorphin (1-5), bovine

[D-Ala2,Met5]- β-Casomorphin (1-5), bovine

CAS No. ———

[D-Ala2,Met5]- β-Casomorphin (1-5), bovine( ——— )

Catalog No. M40964 CAS No. ———

[D-Ala2,Met5]- β-Casomorphin (1-5), bovine

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [D-Ala2,Met5]- β-Casomorphin (1-5), bovine
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Ala2,Met5]- β-Casomorphin (1-5), bovine
  • Description
    [D-Ala2,Met5]- β-Casomorphin (1-5), bovine
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    627.78
  • Molecular Formula
    C31H41N5O7S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Neohesperidose

    Neohesperidose is a natural product isolated from species of?typha.

  • PGP-4008

    PGP-4008 is a selective and potent P-glycoprotein (Pgp) inhibitor that inhibits tumor growth by co-administration with Doxorubicin.

  • FIDAS-5

    FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding.?FIDAS-5 has anticancer activities.?FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM.FIDAS-5 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells.